Pharmacy Search
Vertice Login
Menu
close

Medmonitor

An up-to-date timeline of U.S. Food and Drug Administration (FDA) approvals that could potentially impact workers' compensation. These include new drug and indication approvals, new dosages or formulations of existing products, and generics introduced to the market. Click through the interactive timeline below, or select the comprehensive list view.
← Back to Medmonitor

Medication Type: Hepatitis

Sovaldi (sofosbuvir) tablets

Approval Date: Jan 2022

Note: First-Time Generic

Indicated for the treatment of Hepatitis C genotypes 1-4 in patients without cirrhosis, or with compensated cirrhosis as part of a combination antiviral treatment regimen.

Medication Name

Approval Date

Category

Description

Sovaldi (sofosbuvir) tablets

Jan 2022

Indicated for the treatment of Hepatitis C genotypes 1-4 in patients without cirrhosis, or with compensated cirrhosis as part of a combination antiviral treatment regimen.

Note: First-Time Generic
lockenvelopephone-handsetmagnifiermenucross-circle